Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000897

Type of data
NGS (RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
2.2 TB
File formats
  • FASTQ
  • TXT
Research
hum0445
Date published
2025-05-21
Date modified
2025-11-19

Analysis method

RNA-seq

Materials and participants
Lung adenocarcinoma (ICD10: C34.1, C34.2, C34.3): 362 cases
tumor tissue: 362 samples
non-tumor tissue: 8 samples
  • Health status
    Affected
  • Subject count
    362 (Individual)
Disease
Lung adenocarcinoma (C341, C342, C343)
Sample description
RNAs extracted from tumor/non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
mRNA-Seq Sample Prep Kit
TruSeq RNA Library Prep Kit
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina Genome Analyzer IIx
Illumina HiSeq 2500
Read type
Paired-end
Read length
75 bp
100 bp

WES

Materials and participants
Non-small cell lung cancer (ICD10: C34.9): 8 cases
tumor and non-tumor tissue pairs: 15 pairs, total 30 samples
  • Health status
    Affected
  • Subject count
    8 (Individual)
Disease
Non-small cell lung cancer (C349)
Sample description
DNAs extracted from tumor/non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Illumina NovaSeq 6000
Read type
Paired-end
Read length
HiSeq2500: 75 bp (Paired-end notation)
HiSeq2500: 100 bp (Paired-end notation)
NovaSeq 6000: 150 bp